Comparative Benchmarking
In the context of the broader market, CLDI competes directly with industry leaders such as VIVS and ADVB. With a market capitalization of $2.59M, it holds a significant position in the sector. When comparing efficiency, CLDI's gross margin of N/A stands against VIVS's 100.00% and ADVB's N/A. Such benchmarking helps identify whether Calidi Biotherapeutics Inc is trading at a premium or discount relative to its financial performance.
